{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:01:14Z","timestamp":1760058074205,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Glioblastoma (GMB) is a remarkably aggressive brain malignancy characterized by high mortality rates, despite continuous advances in therapeutic approaches. Compounds derived from plants are being studied for their potent medicinal properties in the quest for more efficient therapies. This study investigated the anti-glioma properties of Methyl rosmarinate, a hydroxycinnamic acid isolated from Thymus thracicus Velen, which has previously demonstrated anti-cancer activity in various cell lines. Human glioblastoma cell lines U87 and T98 were treated with Methyl rosmarinate to assess its effect on cell viability, cell cycle distribution and migratory capacity using Trypan blue assay, flow cytometry and scratch wound healing assay, respectively. The combinatorial effects of Methyl rosmarinate and temozolomide were also analyzed with CompoSyn software. According to the outcomes, Methyl rosmarinate significantly reduced cell viability, induced cell death by interfering in cell cycle checkpoints, and inhibited migration in both GMB cell lines. Notably, in U87 cells, the compound showed a synergistic impact with temozolomide, whereas in T98 cells, there was an antagonistic relationship. These results suggest that Methyl rosmarinate has potential anti-glioma properties; however, more in vivo research is needed.<\/jats:p>","DOI":"10.3390\/cimb47030180","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:59:59Z","timestamp":1741589999000},"page":"180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antineoplastic Activity of Methyl rosmarinate in Glioblastoma Cells"],"prefix":"10.3390","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5569-3056","authenticated-orcid":false,"given":"Maria Vasiliki","family":"Benekou","sequence":"first","affiliation":[{"name":"Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Tzitiridou","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-7632","authenticated-orcid":false,"given":"Theodora","family":"Papagrigoriou","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Galani","sequence":"additional","affiliation":[{"name":"Department of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-4945","authenticated-orcid":false,"given":"Chrissa","family":"Sioka","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-1024","authenticated-orcid":false,"given":"Athanassios P.","family":"Kyritsis","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8864-131X","authenticated-orcid":false,"given":"Diamanto","family":"Lazari","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacognosy, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0257-4481","authenticated-orcid":false,"given":"George A.","family":"Alexiou","sequence":"additional","affiliation":[{"name":"Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece"},{"name":"Department of Neurosurgery, University of Ioannina, 45500 Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Loras, A., Gonzalez-Bonet, L.G., Gutierrez-Arroyo, J.L., Martinez-Cadenas, C., and Marques-Torrejon, M.A. (2023). Neural Stem Cells as Potential Glioblastoma Cells of Origin. Life, 13.","DOI":"10.3390\/life13040905"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Oronsky, B., Reid, T.R., Oronsky, A., Sandhu, N., and Knox, S.J. (2021). A Review of Newly Diagnosed Glioblastoma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.574012"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(99)00122-4","article-title":"A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme","volume":"45","author":"Groves","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lan, Z., Li, X., and Zhang, X. (2024). Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25053040"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"DeCordova, S., Shastri, A., Tsolaki, A.G., Yasmin, H., Klein, L., Singh, S.K., and Kishore, U. (2020). Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01402"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00280-011-1617-9","article-title":"An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting","volume":"67","author":"Kyritsis","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/01635581.2011.523807","article-title":"Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents","volume":"63","author":"Kyritsis","year":"2011","journal-title":"Nutr. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garcia-Oliveira, P., Otero, P., Pereira, A.G., Chamorro, F., Carpena, M., Echave, J., Fraga-Corral, M., Simal-Gandara, J., and Prieto, M.A. (2021). Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment. Pharmaceuticals, 14.","DOI":"10.3390\/ph14020157"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Behl, T., Sharma, A., Sharma, L., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Bungau, S., Toma, M.M., and Gitea, D. (2021). Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme. Cancers, 13.","DOI":"10.3390\/cancers13112765"},{"key":"ref_10","unstructured":"(2024, November 05). Blogspot.com. Available online: https:\/\/florahellenica.blogspot.com\/2014\/04\/thymus-thracicus.html."},{"key":"ref_11","unstructured":"(2024, November 05). Velen|Flora of Greece\u2014An Annotated Checklist. Cybertaxonomy.org. Available online: https:\/\/portal.cybertaxonomy.org\/flora-greece\/cdm_dataportal\/taxon\/e8995434-a703-4c81-b149-aa6c87b0c70d."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12272-022-01378-2","article-title":"Biomedical features and therapeutic potential of rosmarinic acid","volume":"45","author":"Noor","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kernou, O.-N., Azzouz, Z., Madani, K., and Rijo, P. (2023). Application of Rosmarinic Acid with Its Derivatives in the Treatment of Microbial Pathogens. Molecules, 28.","DOI":"10.3390\/molecules28104243"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"604536","DOI":"10.1155\/2013\/604536","article-title":"Rosmarinic Acid and Its Methyl Ester as Antimicrobial Components of the Hydromethanolic Extract of Hyptis atrorubens Poit. (Lamiaceae)","volume":"2013","author":"Abedini","year":"2013","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/bab.2248","article-title":"The antibacterial mechanism of perilla rosmarinic acid","volume":"69","author":"Zhang","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_16","first-page":"2981","article-title":"Chemical constituents of the aerial parts of Salvia judaica Boiss. from Jordan","volume":"34","author":"Tashtoush","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.foodchem.2011.05.039","article-title":"Comparative evaluation of rosmarinic acid, Methyl rosmarinate and pedalitin isolated from Rabdosia serra (MAXIM.) HARA as inhibitors of tyrosinase and \u03b1-glucosidase","volume":"129","author":"Lin","year":"2011","journal-title":"Food Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.sajb.2021.04.030","article-title":"Isolation of rosmarinic acid and Methyl rosmarinate as lipoxygenase inhibitors from Salvia palaestina Benth. by activity-guided fractionation","volume":"141","author":"Bedir","year":"2021","journal-title":"S. Afr. J. Bot."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105841","DOI":"10.1016\/j.antiviral.2024.105841","article-title":"Methyl rosmarinate is an allosteric inhibitor of SARS-CoV-2 3 C L protease as a potential candidate against SARS-CoV-2 infection","volume":"224","author":"Li","year":"2024","journal-title":"Antivir. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Senol Deniz, F.S., Eren, G., Orhan, I.E., Sener, B., Ozgen, U., Aldaba, R., and Calis, I. (2021). Outlining In Vitro and In Silico Cholinesterase Inhibitory Activity of Twenty-Four Natural Products of Various Chemical Classes: Smilagenin, Kokusaginine, and Methyl rosmarinate as Emboldening Inhibitors. Molecules, 26.","DOI":"10.3390\/molecules26072024"},{"key":"ref_21","first-page":"802","article-title":"Methyl rosmarinate induces cell apoptosis in human hepatocellular carcinoma cells via inhibiting the Akt\/mTOR signaling pathways","volume":"57","author":"Xian","year":"2023","journal-title":"J. Xi\u2019an Jiaotong Univ. (Med. Sci.)"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tzitiridou, P., Zoi, V., Papagrigoriou, T., Lazari, D., Sioka, C., Alexiou, G.A., and Kyritsis, A.P. (2024). Antineoplastic Activity of 9\u2033-Lithospermic Acid Methyl Ester in Glioblastoma Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042094"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1080\/14786419.2017.1320789","article-title":"Anti-complementary constituents of Anchusa italica","volume":"31","author":"Hou","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Giannakopoulou, M., Dimitriadis, K., Koromili, M., Zoi, V., Vartholomatos, E., Galani, V., Kyritsis, A.P., Alexiou, G.A., and Lazari, D. (2022). Siderol Inhibits Proliferation of Glioblastoma Cells and Acts Synergistically with Temozolomide. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123216"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zoi, V., Papagrigoriou, T., Tsiftsoglou, O.S., Alexiou, G.A., Giannakopoulou, M., Tzima, E., Tsekeris, P., Zikou, A., Kyritsis, A.P., and Lazari, D. (2023). Therapeutic Potential of Linearol in Combination with Radiotherapy for the Treatment of Glioblastoma In Vitro. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043760"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Burster, T., Traut, R., Yermekkyzy, Z., Mayer, K., Westhoff, M.-A., Bischof, J., and Knippschild, U. (2021). Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.695325"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Uddin, M.S., Kabir, M.T., Mamun, A.A., Sarwar, M.S., Nasrin, F., Emran, T.B., Alanazi, I.S., Rauf, A., Albadrani, G.M., and Sayed, A.A. (2021). Natural Small Molecules Targeting NF-\u03baB Signaling in Glioblastoma. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.703761"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/0118715257262003231031171910","article-title":"An Insight into Emerging Phytocompounds for Glioblastoma Multiforme Therapy","volume":"22","author":"Prakash","year":"2023","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Mart\u00ednez, J.D., Vald\u00e9s, A., Gallego, R., Su\u00e1rez-Montenegro, Z.J., Alarc\u00f3n, M., Iba\u00f1ez, E., Alvarez-Rivera, G., and Cifuentes, A. (2022). Blood\u2013Brain Barrier Permeability Study of Potential Neuroprotective Compounds Recovered From Plants and Agri-Food by-Products. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.924596"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejmech.2012.09.047","article-title":"Synthesis of derivatives of Methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1)","volume":"62","author":"Yuan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_31","first-page":"145","article-title":"Systems Pharmacology and Molecular Docking Reveals the Potential Beneficial effect of Rabdosia serra in Treating liver Cancer","volume":"7","author":"Ismael","year":"2023","journal-title":"J. Pharm. Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.52635\/eamr\/13.2.158-168","article-title":"Potential cytotoxic and antiangiogenic properties of Ehretia microphylla leaf ethanolic extract through the modulation of MEK and VEGFR 2","volume":"13","author":"Eclarin","year":"2023","journal-title":"Explor. Anim. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cac2.12361","article-title":"An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment","volume":"42","author":"Verdugo","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"33440","DOI":"10.18632\/oncotarget.7961","article-title":"PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41392-023-01637-8","article-title":"From signalling pathways to targeted therapies: Unravelling glioblastoma\u2019s secrets and harnessing two decades of progress","volume":"8","author":"Dewdney","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/JCMA.0000000000000552","article-title":"Overview of the molecular mechanisms of migration and invasion in glioblastoma multiforme","volume":"84","author":"Liu","year":"2021","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Lieftink, C., and Beijersbergen, R.L. (2021). It takes two to tango, and the right music: Synergistic drug combinations with cell-cycle phase-dependent sensitivities. eBioMedicine, 69.","DOI":"10.1016\/j.ebiom.2021.103448"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Proto, M.C., Fiore, D., Piscopo, C., Laezza, C., Bifulco, M., and Gazzerro, P. (2022). Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.815646"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"60245","DOI":"10.18632\/oncotarget.11197","article-title":"Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status","volume":"7","author":"Patyka","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.trecan.2020.02.010","article-title":"MGMT Status as a Clinical Biomarker in Glioblastoma","volume":"6","author":"Butler","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dymova, M.A., Kuligina, E.V., and Richter, V.A. (2021). Molecular Mechanisms of Drug Resistance in Glioblastoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126385"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/3\/180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:59Z","timestamp":1760028599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/3\/180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["cimb47030180"],"URL":"https:\/\/doi.org\/10.3390\/cimb47030180","relation":{},"ISSN":["1467-3045"],"issn-type":[{"type":"electronic","value":"1467-3045"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}